Literature DB >> 860672

Modification of adriamycin toxicity in rats fed a high fat diet.

G Zbinden, E Brändle, M Pfister.   

Abstract

Rats fed a diet containing a high percentage of butter, cholesterol, cholic acid and proply thiouracil (HFD) showed weight loss and developed hyperlipidemia, marked fatty infiltration of the liver, moderate elevation of SGPT, degenerative changes of the heart muscle, bradycardia, alterations of the QRS complex in the electrocardiogram, and initial hemoconcentration followed by moderate anemia. Treatment with adriamycin (18 X 1 mg/kg i.p.) resulted in significant augmentation of the cardiotoxic effects of this drug demonstrated by electrocardiographic measurements and myocardial histopathology. Adriamycin-induced atrophy of the lymphatic tissue was seen only in rats fed HFD and not in animals receiving ground chow. Adriamycin levels in the heart after single i.p. injection were higher in rats receiving HFD. This effect was present already after 10 days on HFD. At this time histopathological liver changes were present and SGPT was elevated. It is concluded that the increase in adriamycin toxicity is, at least in part, due to diminished excretion by the liver. These experimental findings are in accordance with clinical observations which have identified liver disease as one of the important risk factors for the development of adriamycin cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 860672     DOI: 10.1007/BF01964915

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  12 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Thromobosis in connection with serum lipidic changes in the rat.

Authors:  S RENAUD; C ALLARD
Journal:  Circ Res       Date:  1962-09       Impact factor: 17.367

3.  Daunorubicin biliary excretion and metabolism in the rat.

Authors:  J C Cradock; M J Egorin; N R Bachur
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-03

4.  Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods.

Authors:  N R Bachur; A L Moore; J G Bernstein; A Liu
Journal:  Cancer Chemother Rep       Date:  1970-04

5.  Daunomycin metabolism in rat tissue slices.

Authors:  N R Bachur; J C Cradock
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

6.  Adriamycin (NSC-123,127): a new antibiotic with antitumor activity.

Authors:  A Di Marco; M Gaetani; B Scarpinato
Journal:  Cancer Chemother Rep       Date:  1969-02

7.  Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-D and mithramycin.

Authors:  J P Kushner; V L Hansen; S P Hammar
Journal:  Cancer       Date:  1975-11       Impact factor: 6.860

8.  The cardiotoxicity of adriamycin and daunomycin in children.

Authors:  A C Gilladoga; C Manuel; C T Tan; N Wollner; S S Sternberg; M L Murphy
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

9.  Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats.

Authors:  G Zbinden; E Brändle
Journal:  Cancer Chemother Rep       Date:  1975 Jul-Aug

10.  Clinical evaluation of adriamycin, a new antitumour antibiotic.

Authors:  G Bonadonna; S Monfardini; M De Lena; F Fossati-Bellani
Journal:  Br Med J       Date:  1969-08-30
View more
  1 in total

1.  Recirculating, retrograde heart perfusion according to Langendorff as a tool in the evaluation of drug-induced cardiomyopathy: effects of a high lipid diet.

Authors:  E Bachmann; E Weber
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.